1. Home
  2. NEO vs MRCY Comparison

NEO vs MRCY Comparison

Compare NEO & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • MRCY
  • Stock Information
  • Founded
  • NEO 2001
  • MRCY 1981
  • Country
  • NEO United States
  • MRCY United States
  • Employees
  • NEO N/A
  • MRCY N/A
  • Industry
  • NEO Precision Instruments
  • MRCY
  • Sector
  • NEO Health Care
  • MRCY
  • Exchange
  • NEO Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • NEO 1.9B
  • MRCY 2.2B
  • IPO Year
  • NEO 1999
  • MRCY 1998
  • Fundamental
  • Price
  • NEO $14.11
  • MRCY $48.90
  • Analyst Decision
  • NEO Strong Buy
  • MRCY Hold
  • Analyst Count
  • NEO 10
  • MRCY 7
  • Target Price
  • NEO $20.44
  • MRCY $39.14
  • AVG Volume (30 Days)
  • NEO 1.2M
  • MRCY 359.2K
  • Earning Date
  • NEO 02-18-2025
  • MRCY 02-04-2025
  • Dividend Yield
  • NEO N/A
  • MRCY N/A
  • EPS Growth
  • NEO N/A
  • MRCY N/A
  • EPS
  • NEO N/A
  • MRCY N/A
  • Revenue
  • NEO $644,118,000.00
  • MRCY $858,715,000.00
  • Revenue This Year
  • NEO $13.00
  • MRCY $3.92
  • Revenue Next Year
  • NEO $10.10
  • MRCY $6.30
  • P/E Ratio
  • NEO N/A
  • MRCY N/A
  • Revenue Growth
  • NEO 12.06
  • MRCY N/A
  • 52 Week Low
  • NEO $12.13
  • MRCY $25.31
  • 52 Week High
  • NEO $19.11
  • MRCY $44.63
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.08
  • MRCY 52.96
  • Support Level
  • NEO $13.76
  • MRCY $40.24
  • Resistance Level
  • NEO $15.26
  • MRCY $43.05
  • Average True Range (ATR)
  • NEO 0.68
  • MRCY 1.42
  • MACD
  • NEO -0.02
  • MRCY -0.19
  • Stochastic Oscillator
  • NEO 7.85
  • MRCY 51.54

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: